Show Less
Restricted access

Methodological Advances in the Economic Evaluation of Infectious Disease Prevention

The Case of Chlamydial Screening and Meningococcal C Vaccination


Robert Welte

Contents: Cost-effectiveness of screening for genital Chlamydia trachomatis infections – Cost-effectiveness of screening programs for Chlamydia trachomatis: a population based dynamic approach – Cost and effects of chlamydial screening programs: dynamic versus static modeling – The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine – Economic evaluation of meningococcal serogroup C conjugate vaccination programs in The Netherlands and its impact on decision making – A decision chart for assessing and improving the transferability of economic evaluation results between countries.